Marielle Verheul, Anne A Wagenmakers, Rob G H H Nelissen, Peter H Nibbering, Bart G Pijls
{"title":"感应加热联合抗生素或SAAP-148有效减少骨折相关假体模拟物上生物膜嵌入的金黄色葡萄球菌。","authors":"Marielle Verheul, Anne A Wagenmakers, Rob G H H Nelissen, Peter H Nibbering, Bart G Pijls","doi":"10.1302/2046-3758.145.BJR-2024-0341.R1","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>Fracture-related infections and the associated treatment failure burden our society and healthcare system significantly. As an alternative approach, we investigated the effect of non-contact induction heating (NCIH) against <i>Staphylococcus aureus</i> within mature biofilms. In addition, we assessed the ability of antibiotics, the antimicrobial peptide SAAP-148, and bacteriophage (phage) ISP to enhance the efficacy of NCIH, thereby allowing the use of lower temperatures during NCIH.</p><p><strong>Methods: </strong>Clinical isolates of methicillin-resistant and methicillin-sensitive <i>S. aureus</i> (methicillin-resistant <i>S. aureus</i> (MRSA), methicillin-sensitive <i>S. aureus</i> (MSSA)) were cultured for seven days on Ti-6Al-7Nb (mimicking fracture plates) discs to obtain mature biofilms. Biofilms were exposed to 60°C to 80°C NCIH. In addition, biofilms were sequentially exposed to 60°C to 70°C NCIH and rifampicin/ciprofloxacin, SAAP-148, or phage ISP. Biofilm-embedded bacteria were harvested by sonication to determine the bacterial load and visualized by confocal microscopy (LIVE/DEAD).</p><p><strong>Results: </strong>NCIH to 60°C, 70°C, and 80°C reduced biofilm-embedded MRSA and MSSA by 2.3-log, 4.9-log, 5.5-log, and 1.1-log, 3.4-log, and 6.6-log CFU/ml, respectively. LIVE/DEAD staining revealed NCIH-induced bacterial cell death throughout the biofilm layers. The sequential combination of rifampicin/ciprofloxacin at 10 µg/ml and 1,280 µg/ml (MRSA) or 156 µg/l and 64 µg/ml (MSSA) and 70°C NCIH synergistically reduced biofilm-embedded bacteria by 2.7-log and 3.7-log CFU/ml, respectively, while the alternating exposure order reduced bacterial counts by -0.1 and 1.7-log CFU/ml. SAAP-148 at 51.2 µM followed by 70°C NCIH further diminished biofilm-embedded MRSA and MSSA by 2.3-log and 1.5-log CFU/ml, respectively. No significant reductions were observed for NCIH combined with phage ISP compared to these treatments alone.</p><p><strong>Conclusion: </strong>NCIH effectively reduced biofilm-embedded <i>S. aureus</i> on Ti-6Al-7Nb in a heat-dependent fashion. Rifampicin/ciprofloxacin and SAAP-148, but not phage ISP, enhanced the efficacy of NCIH. Antibiotic exposure at suboptimal concentrations followed by NCIH was more effective than vice versa, suggesting that the application of this approach might be most suitable in clinical situations where antibiotic treatment has already started.</p>","PeriodicalId":9074,"journal":{"name":"Bone & Joint Research","volume":"14 5","pages":"485-494"},"PeriodicalIF":4.7000,"publicationDate":"2025-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12088828/pdf/","citationCount":"0","resultStr":"{\"title\":\"Induction heating combined with antibiotics or SAAP-148 effectively reduces biofilm-embedded Staphylococcus aureus on a fracture-related implant mimic.\",\"authors\":\"Marielle Verheul, Anne A Wagenmakers, Rob G H H Nelissen, Peter H Nibbering, Bart G Pijls\",\"doi\":\"10.1302/2046-3758.145.BJR-2024-0341.R1\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Aims: </strong>Fracture-related infections and the associated treatment failure burden our society and healthcare system significantly. As an alternative approach, we investigated the effect of non-contact induction heating (NCIH) against <i>Staphylococcus aureus</i> within mature biofilms. In addition, we assessed the ability of antibiotics, the antimicrobial peptide SAAP-148, and bacteriophage (phage) ISP to enhance the efficacy of NCIH, thereby allowing the use of lower temperatures during NCIH.</p><p><strong>Methods: </strong>Clinical isolates of methicillin-resistant and methicillin-sensitive <i>S. aureus</i> (methicillin-resistant <i>S. aureus</i> (MRSA), methicillin-sensitive <i>S. aureus</i> (MSSA)) were cultured for seven days on Ti-6Al-7Nb (mimicking fracture plates) discs to obtain mature biofilms. Biofilms were exposed to 60°C to 80°C NCIH. In addition, biofilms were sequentially exposed to 60°C to 70°C NCIH and rifampicin/ciprofloxacin, SAAP-148, or phage ISP. Biofilm-embedded bacteria were harvested by sonication to determine the bacterial load and visualized by confocal microscopy (LIVE/DEAD).</p><p><strong>Results: </strong>NCIH to 60°C, 70°C, and 80°C reduced biofilm-embedded MRSA and MSSA by 2.3-log, 4.9-log, 5.5-log, and 1.1-log, 3.4-log, and 6.6-log CFU/ml, respectively. LIVE/DEAD staining revealed NCIH-induced bacterial cell death throughout the biofilm layers. The sequential combination of rifampicin/ciprofloxacin at 10 µg/ml and 1,280 µg/ml (MRSA) or 156 µg/l and 64 µg/ml (MSSA) and 70°C NCIH synergistically reduced biofilm-embedded bacteria by 2.7-log and 3.7-log CFU/ml, respectively, while the alternating exposure order reduced bacterial counts by -0.1 and 1.7-log CFU/ml. SAAP-148 at 51.2 µM followed by 70°C NCIH further diminished biofilm-embedded MRSA and MSSA by 2.3-log and 1.5-log CFU/ml, respectively. No significant reductions were observed for NCIH combined with phage ISP compared to these treatments alone.</p><p><strong>Conclusion: </strong>NCIH effectively reduced biofilm-embedded <i>S. aureus</i> on Ti-6Al-7Nb in a heat-dependent fashion. Rifampicin/ciprofloxacin and SAAP-148, but not phage ISP, enhanced the efficacy of NCIH. Antibiotic exposure at suboptimal concentrations followed by NCIH was more effective than vice versa, suggesting that the application of this approach might be most suitable in clinical situations where antibiotic treatment has already started.</p>\",\"PeriodicalId\":9074,\"journal\":{\"name\":\"Bone & Joint Research\",\"volume\":\"14 5\",\"pages\":\"485-494\"},\"PeriodicalIF\":4.7000,\"publicationDate\":\"2025-05-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12088828/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Bone & Joint Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1302/2046-3758.145.BJR-2024-0341.R1\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CELL & TISSUE ENGINEERING\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bone & Joint Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1302/2046-3758.145.BJR-2024-0341.R1","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CELL & TISSUE ENGINEERING","Score":null,"Total":0}
引用次数: 0
摘要
目的:骨折相关感染及其治疗失败给我们的社会和医疗保健系统带来了巨大的负担。作为一种替代方法,我们研究了非接触感应加热(NCIH)对成熟生物膜内金黄色葡萄球菌的影响。此外,我们评估了抗生素、抗菌肽SAAP-148和噬菌体ISP增强NCIH疗效的能力,从而允许在NCIH期间使用较低的温度。方法:将临床分离的耐甲氧西林金黄色葡萄球菌(methicillin-resistant S. aureus, MRSA)和耐甲氧西林金黄色葡萄球菌(methicillin-sensitive S. aureus, MSSA)在Ti-6Al-7Nb(模拟骨折板)椎间盘上培养7 d,获得成熟的生物膜。生物膜暴露于60°C至80°C的NCIH中。此外,生物膜依次暴露于60°C至70°C的NCIH和利福平/环丙沙星、SAAP-148或噬菌体ISP中。通过超声收集包埋生物膜的细菌以确定细菌负荷,并通过共聚焦显微镜(LIVE/DEAD)观察。结果:NCIH至60°C、70°C和80°C时,生物膜包埋MRSA和MSSA分别降低2.3、4.9、5.5、1.1、3.4和6.6 log CFU/ml。LIVE/DEAD染色显示ncih诱导的细菌细胞死亡贯穿整个生物膜层。利福平/环丙沙星在10µg/ml和1280µg/ml (MRSA)或156µg/l和64µg/ml (MSSA)和70°C NCIH下的顺序组合分别协同减少生物膜包埋细菌2.7和3.7 log CFU/ml,而交替暴露顺序减少细菌计数-0.1和1.7 log CFU/ml。SAAP-148在51.2µM的温度下,再经过70°C的NCIH,进一步降低了生物膜包埋的MRSA和MSSA,分别降低了2.3和1.5 log CFU/ml。与单独治疗相比,未观察到NCIH联合噬菌体ISP的显著降低。结论:NCIH以热依赖的方式有效地减少了Ti-6Al-7Nb上生物膜包埋的金黄色葡萄球菌。利福平/环丙沙星和SAAP-148可提高NCIH的疗效,而噬菌体ISP不能提高NCIH的疗效。在次优浓度下暴露抗生素然后进行NCIH比反之更有效,这表明这种方法的应用可能最适合已经开始抗生素治疗的临床情况。
Induction heating combined with antibiotics or SAAP-148 effectively reduces biofilm-embedded Staphylococcus aureus on a fracture-related implant mimic.
Aims: Fracture-related infections and the associated treatment failure burden our society and healthcare system significantly. As an alternative approach, we investigated the effect of non-contact induction heating (NCIH) against Staphylococcus aureus within mature biofilms. In addition, we assessed the ability of antibiotics, the antimicrobial peptide SAAP-148, and bacteriophage (phage) ISP to enhance the efficacy of NCIH, thereby allowing the use of lower temperatures during NCIH.
Methods: Clinical isolates of methicillin-resistant and methicillin-sensitive S. aureus (methicillin-resistant S. aureus (MRSA), methicillin-sensitive S. aureus (MSSA)) were cultured for seven days on Ti-6Al-7Nb (mimicking fracture plates) discs to obtain mature biofilms. Biofilms were exposed to 60°C to 80°C NCIH. In addition, biofilms were sequentially exposed to 60°C to 70°C NCIH and rifampicin/ciprofloxacin, SAAP-148, or phage ISP. Biofilm-embedded bacteria were harvested by sonication to determine the bacterial load and visualized by confocal microscopy (LIVE/DEAD).
Results: NCIH to 60°C, 70°C, and 80°C reduced biofilm-embedded MRSA and MSSA by 2.3-log, 4.9-log, 5.5-log, and 1.1-log, 3.4-log, and 6.6-log CFU/ml, respectively. LIVE/DEAD staining revealed NCIH-induced bacterial cell death throughout the biofilm layers. The sequential combination of rifampicin/ciprofloxacin at 10 µg/ml and 1,280 µg/ml (MRSA) or 156 µg/l and 64 µg/ml (MSSA) and 70°C NCIH synergistically reduced biofilm-embedded bacteria by 2.7-log and 3.7-log CFU/ml, respectively, while the alternating exposure order reduced bacterial counts by -0.1 and 1.7-log CFU/ml. SAAP-148 at 51.2 µM followed by 70°C NCIH further diminished biofilm-embedded MRSA and MSSA by 2.3-log and 1.5-log CFU/ml, respectively. No significant reductions were observed for NCIH combined with phage ISP compared to these treatments alone.
Conclusion: NCIH effectively reduced biofilm-embedded S. aureus on Ti-6Al-7Nb in a heat-dependent fashion. Rifampicin/ciprofloxacin and SAAP-148, but not phage ISP, enhanced the efficacy of NCIH. Antibiotic exposure at suboptimal concentrations followed by NCIH was more effective than vice versa, suggesting that the application of this approach might be most suitable in clinical situations where antibiotic treatment has already started.